US Stock and Financial News

Health Catalyst Down 37% After Lower Guidance, Price Target Cuts

By Josh Beckerman Health Catalyst Inc. shares fell 37%, to $11.46, after it lowered 2022 revenue guidance and price targets were cut by Stifel and JPMorgan….

Related Articles

Back to top button